Clinical trials
Completed Phase 3 trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,496 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 17 |
| 2002 | 15 |
| 2003 | 37 |
| 2004 | 43 |
| 2005 | 55 |
| 2006 | 103 |
| 2007 | 83 |
| 2008 | 87 |
| 2009 | 79 |
| 2010 | 81 |
| 2011 | 80 |
| 2012 | 79 |
| 2013 | 80 |
| 2014 | 74 |
| 2015 | 80 |
| 2016 | 70 |
| 2017 | 64 |
| 2018 | 70 |
| 2019 | 76 |
| 2020 | 59 |
| 2021 | 46 |
| 2022 | 40 |
| 2023 | 39 |
| 2024 | 18 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,496 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 117 |
| Eli Lilly and Company | 103 |
| AstraZeneca | 96 |
| Hoffmann-La Roche | 95 |
| Sanofi | 86 |
| GlaxoSmithKline | 81 |
| Bristol-Myers Squibb | 77 |
| Boehringer Ingelheim | 62 |
| Pfizer | 56 |
| Bayer | 55 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 128 |
| Breast Neoplasms | 64 |
| Diabetes Mellitus | 62 |
| Arthritis, Rheumatoid | 60 |
| Asthma | 60 |
| Pulmonary Disease, Chronic Obstructive | 58 |
| Carcinoma, Non-Small-Cell Lung | 44 |
| HIV Infections | 28 |
| Neoplasms | 27 |
| Cardiovascular Diseases | 25 |
Trials
Showing 1 to 25 of 1,496. Each trial links to its page on Pharma Observatory.
1,396 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.